Study to Access Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Compound S0597 by Oral Inhalation: A Phase I/IIa Observer and Double Blind, Placebo and Active Controlled Parallel and Crossover Study.
Phase of Trial: Phase I/II
Latest Information Update: 07 Apr 2016
Price : $35 *
At a glance
- Drugs SUN 0597 (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Sun Pharma Advanced Research Company
- 30 Mar 2016 No of arms changed from 3 to 6 as per ClinicalTrials.gov record.
- 30 Mar 2016 Status changed from not yet recruiting to completed as per ClinicalTrials.gov record.
- 25 Feb 2014 New trial record